Search

Your search keyword '"Arver, Brita"' showing total 430 results

Search Constraints

Start Over You searched for: Author "Arver, Brita" Remove constraint Author: "Arver, Brita"
430 results on '"Arver, Brita"'

Search Results

2. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.

3. Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus.

4. Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus

5. An international survey of surveillance schemes for unaffected BRCA1 and BRCA2 mutation carriers

6. No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer

7. Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.

8. A search for modifying genetic factors in CHEK2:c.1100delC breast cancer patients

10. DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriers.

12. Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers

13. Individuals with FANCM biallelic mutations do not develop Fanconi anemia, but show risk for breast cancer, chemotherapy toxicity and may display chromosome fragility

16. Clinical assessment of breast symmetry and aesthetic outcome : Can 3D imaging be the gold standard?

17. No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer

21. Patient-reported outcomes and 3-dimensional surface imaging after risk-reducing mastectomy and immediate breast reconstruction

22. Impact of preoperative breast MRI on 10-year survival outcome of patients included in the Swedish randomized multicenter POMB trial

26. Alcohol Consumption, Cigarette Smoking, and Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Results from The BRCA1 and BRCA2 Cohort Consortium

27. Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers

28. Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness

29. Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers (vol 22, 8, 2020)

30. Alcohol Consumption, Cigarette Smoking, and Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers:Results from The BRCA1 and BRCA2 Cohort Consortium

31. Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk:an international prospective cohort of BRCA1 and BRCA2 mutation carriers

32. Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness

33. Alcohol consumption, cigarette smoking, and risk of breast cancer for BRCA1 and BRCA2 mutation carriers: results from The BRCA1 and BRCA2 Cohort Consortium

35. Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers

36. Genetic Variation at 9p22.2 and Ovarian Cancer Risk for BRCA1 and BRCA2 Mutation Carriers

37. Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness

39. The accuracy of incremental pre-operative breast MRI findings - Concordance with histopathology in the Swedish randomized multicenter POMB trial

40. Tumour spectrum in non-BRCA hereditary breast cancer families in Sweden

42. Risk perception after genetic counseling in patients with increased risk of cancer

43. Individuals with &ITFANCM&IT biallelic mutations do not develop Fanconi anemia, but show risk for breast cancer, chemotherapy toxicity and may display chromosome fragility

44. The Influence of Number and Timing of Pregnancies on Breast Cancer Risk for Women With BRCA1 or BRCA2 Mutations

45. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

46. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

47. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

48. No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer

49. Additional file 4: Table S5. of Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus

50. Additional file 2: Table S3. of Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus

Catalog

Books, media, physical & digital resources